Ronovo Surgical’s Carina robot gains $67M boost, J&J deal

Ronovo Surgical, a Shanghai-based company, has secured $67 million in its Series D financing round, led by Johnson & Johnson’s corporate venture capital arm, JJDC. This latest funding adds to previous rounds, bringing Ronovo’s total capital raised to over $100 million in 2025. Alongside the financing, Ronovo entered a targeted collaboration with Johnson & Johnson to promote commercialization of its Carina modular robotic surgery platform in China. The partnership aims to provide hospitals in parts of China access to Carina’s technology combined with complementary J&J MedTech surgical tools. The Carina platform, unveiled in February 2023, is a modular, configurable robotic system designed to assist laparoscopic surgeries across multiple specialties, including general surgery, gynecology, urology, and thoracic surgery. It addresses key challenges in minimally invasive procedures by offering surgeons flexibility in instrument choice and anatomical access. In March 2025, Carina received approval from China’s National Medical Products Administration (NMP